These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 32444132

  • 1. Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
    Tojimbara T, Yashima J, Shirai H, Yamazaki T, Koyama I, Nakajima I.
    Transplant Proc; 2020; 52(6):1705-1708. PubMed ID: 32444132
    [Abstract] [Full Text] [Related]

  • 2. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol.
    Ando T, Tojimbara T, Sato S, Nakamura M, Kawase T, Kai K, Nakajima I, Fuchinoue S, Teraoka S.
    Transplant Proc; 2004 Sep 20; 36(7):2182-3. PubMed ID: 15518793
    [Abstract] [Full Text] [Related]

  • 4. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K, Saito K, Takahara S, Fuchinoue S, Yagisawa T, Aikawa A, Watarai Y, Yoshimura N, Tanabe K, Morozumi K, Shimazu M, IDEC-C2B8 ABO-I KTx Study Group.
    Clin Exp Nephrol; 2017 Aug 20; 21(4):705-713. PubMed ID: 27534951
    [Abstract] [Full Text] [Related]

  • 5. ABO-incompatible kidney transplantation in elderly patients over 60 years of age.
    Uchida J, Iwai T, Machida Y, Kuwabara N, Kabei K, Murao M, Otoshi T, Naganuma T, Kumada N, Nakatani T.
    Int Urol Nephrol; 2012 Oct 20; 44(5):1563-70. PubMed ID: 22828739
    [Abstract] [Full Text] [Related]

  • 6. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C.
    Transplant Proc; 2020 Oct 20; 52(6):1700-1704. PubMed ID: 32448659
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.
    Uchida J, Machida Y, Iwai T, Naganuma T, Kitamoto K, Iguchi T, Maeda S, Kamada Y, Kuwabara N, Kim T, Nakatani T.
    Transplant Proc; 2010 Dec 20; 42(10):3998-4002. PubMed ID: 21168610
    [Abstract] [Full Text] [Related]

  • 10. Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus.
    Nanmoku K, Shinzato T, Kubo T, Shimizu T, Kimura T, Yagisawa T.
    Transplant Proc; 2018 May 20; 50(4):1050-1055. PubMed ID: 29631750
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y, Aikawa A, Itabashi Y, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Kawamura T, Sakai K, Shishido S.
    Exp Clin Transplant; 2019 Jan 20; 17(Suppl 1):105-109. PubMed ID: 30777532
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K.
    Transplantation; 1998 Jan 27; 65(2):224-8. PubMed ID: 9458019
    [Abstract] [Full Text] [Related]

  • 13. Acute Anti-A/B Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplantation Treated With Bortezomib and Plasmapheresis: A Case Report.
    Lee JH, Lee H, Kim K, Lee SW, Song JH, Hwang SD.
    Transplant Proc; 2022 Mar 27; 54(2):540-543. PubMed ID: 35067375
    [Abstract] [Full Text] [Related]

  • 14. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
    Saito K, Nakagawa Y, Suwa M, Kumagai N, Tanikawa T, Nishiyama T, Ueno M, Gejyo F, Nishi S, Takahashi K.
    Xenotransplantation; 2006 Mar 27; 13(2):111-7. PubMed ID: 16623803
    [Abstract] [Full Text] [Related]

  • 15. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, Itabashi Y, Hyodo Y, Ohashi Y, Aikawa A, Sakai K, Shishido S.
    Pediatr Nephrol; 2020 Jan 27; 35(1):95-102. PubMed ID: 31673829
    [Abstract] [Full Text] [Related]

  • 16. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
    Nanmoku K, Shinzato T, Kubo T, Shimizu T, Kimura T, Yagisawa T.
    Transplant Proc; 2018 May 27; 50(4):982-986. PubMed ID: 29731097
    [Abstract] [Full Text] [Related]

  • 17. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.
    Shen T, Lin BY, Jia JJ, Wang ZY, Wang L, Ling Q, Geng L, Yan S, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2014 Aug 27; 13(4):395-401. PubMed ID: 25100124
    [Abstract] [Full Text] [Related]

  • 18. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation.
    Stojanovic J, Adamusiak A, Kessaris N, Chandak P, Ahmed Z, Sebire NJ, Walsh G, Jones HE, Marks SD, Mamode N.
    Transplantation; 2017 Jun 27; 101(6):1242-1246. PubMed ID: 27463537
    [Abstract] [Full Text] [Related]

  • 19. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil.
    Kabei K, Uchida J, Iwai T, Yamasaki T, Kuwabara N, Naganuma T, Kumada N, Nakatani T.
    Transpl Immunol; 2014 Aug 27; 31(2):92-7. PubMed ID: 24932811
    [Abstract] [Full Text] [Related]

  • 20. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O, Wiesener M, Opgenoorth M, Pascher A, Woitas RP, Witzke O, Jaenigen B, Rentsch M, Wolters H, Rath T, Cingöz T, Benck U, Banas B, Hugo C.
    Lancet; 2016 Dec 17; 388(10063):3006-3016. PubMed ID: 27871759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.